For Korean breast cancer patients, the prevalence of BRCA1/2 mutation for patients with a family history of breast or ovarian cancer is 22.3% [9], and the cumulative risk of breast cancer is 72.1% for BRCA1 and 66.3% for BRCA2 mutation carriers [10]. This evidence concerns the gene BRCA2 and ovarian carcinoma.